On June 13, 2019 Oncopeptides AB (Nasdaq Stockholm: ONCO), reported that the company will make a review and update on the presented data from the European Hematology Meeting (EHA) (Free EHA Whitepaper) on Monday, June 17, 2019, at. 09:00 (CET) (Press release, Oncopeptides, JUN 13, 2019, View Source [SID1234537055]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

It will be presented by CEO Jakob Lindberg and members of the Oncopeptide management team.

The conference call can also be followed via the link: View Source

Phone numbers for participants from:
Sweden: +46 8 566 427 06
Europe: +44 3333 009 030
USA: +1 833 526 8384

For further information, please contact:
Rein Piir, Head of Investor Relations at Oncopeptides
E-mail: [email protected]
Cell phone: +46 70 853 72 92

This information was submitted for publication at 09:00 CET, 13 June 2019